Application of in-silico drug discovery techniques to discover a novel hit for target-specific inhibition of SARS-CoV-2 Mpro’s revealed allosteric binding with MAO-B receptor: A theoretical study to find a cure for post-covid neurological disorder

Ähnliche Einträge

• Application of in-silico drug discovery techniques to discover a novel hit for target-specific inhibition of SARS-CoV-2 Mpro's revealed allosteric binding with MAO-B receptor: A theoretical study to find a cure for post-covid neurological disorder.
  von: Magdi E A Zaki, et al.
  Veröffentlicht: (2024-01-01)
• In-silico studies to recognize repurposing therapeutics toward arginase-I inhibitors as a potential onco-immunomodulators
  von: Magdi E. A. Zaki, et al.
  Veröffentlicht: (2023-04-01)
• Mechanistic Analysis of Chemically Diverse Bromodomain-4 Inhibitors Using Balanced QSAR Analysis and Supported by X-ray Resolved Crystal Structures
  von: Magdi E. A. Zaki, et al.
  Veröffentlicht: (2022-06-01)
• Cheminformatics approaches to predict the bioactivity and to discover the pharmacophoric traits crucial to block NF-κB
  von: Rahul D. Jawarkar, et al.
  Veröffentlicht: (2024-12-01)
• Molecular docking, QSAR, and ADME studies of some pyrrolo[1, 2-a] benzimidazole-based quinones as novel topoisomerase 2 beta (TOP2β) inhibitors
  von: Rahul D. Jawarkar, et al.
  Veröffentlicht: (2024-06-01)